On September 1, 2026 Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, reported that it will webcast its presentations at four investor conferences in September. The presentations will feature a business overview and update.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Sana will present at the 2026 Wells Fargo Healthcare Conference at 9:30 a.m. ET on Tuesday, September 8, 2026.
Sana will present at Citi’s 2026 Biopharma Back-to-School Conference at 1:40 p.m. ET on Thursday, September 10, 2026.
Sana will present at the Morgan Stanley 24th Annual Global Healthcare Conference at 4:50 p.m. ET on Monday, September 14, 2026.
Sana will present at the HC Wainwright 28th Annual Global Investment Conference at 11:30 a.m. ET on Tuesday, September 15, 2026.
The webcasts will be accessible on the Investor Relations page of Sana’s website at View Source A replay of each presentation will be available at the same location for 30 days following the conference.
(Press release, Sana Biotechnology, SEP 1, 2026, View Source [SID1234670495])